AnaptysBio, Inc. (ANAB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Cash Flow
All numbers in thousandsBreakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-163,619
-163,619
-128,724
-57,796
-19,931
Depreciation & amortization
2,376
2,376
2,335
2,090
1,617
Stock based compensation
33,205
33,205
27,356
15,347
11,499
Change in working capital
-324
-324
6,839
-7,489
-7,829
Accounts receivable
-5,432
-5,432
-543
-876
0
Accounts Payable
10,938
10,938
9,700
-4,740
-7,694
Other working capital
-121,607
-121,607
-73,951
-47,286
-14,726
Other non-cash items
676
18,083
21,108
1,450
-
Net cash provided by operating activites
-120,800
-120,800
-73,593
-45,920
-14,157
Cash flows from investing activities
Investments in property, plant and equipment
-807
-807
-358
-1,366
-569
Purchases of investments
-303,919
-303,919
-802,503
-118,662
-194,927
Sales/Maturities of investments
449,480
449,480
408,016
158,848
289,971
Net cash used for investing activites
144,754
144,754
-394,845
38,835
94,475
Cash flows from financing activities
Debt repayment
-
-
0
0
-1,375
Common stock issued
2,472
2,472
11,827
2,553
496
Common stock repurchased
-50,000
-50,000
0
0
-
Other financing activites
-11,769
-11,769
32,190
249,745
-
Net cash used privided by (used for) financing activities
-59,297
-59,297
44,017
252,298
-879
Net change in cash
-35,343
-35,343
-424,421
245,213
79,439
Cash at beginning of period
71,308
71,308
495,729
250,516
171,077
Cash at end of period
35,965
35,965
71,308
495,729
250,516
Free Cash Flow
Operating Cash Flow
-120,800
-120,800
-73,593
-45,920
-14,157
Capital Expenditure
-807
-807
-358
-1,366
-569
Free Cash Flow
-121,607
-121,607
-73,951
-47,286
-14,726
© 2024 Yahoo. All rights reserved.